Catalent Pharma Solutions, Inc.

Catalent Pharma Solutions, Inc. (United States) holds 0 active US FDA Type II Drug Master Files and 74 inactive, has DMF or CEP filings on record for 4 active ingredients, holds 3 active Type IV (excipient) Drug Master Files and is linked to 14 FDA-registered manufacturing sites. 18 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Catalent Pharma Solutions, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/catalent-pharma-solutions-inc

Overview

Catalent Pharma Solutions, Inc. is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. With a strong focus on innovation and customer partnership, Catalent enables better treatments across more than 50 countries worldwide.

Core services & business areas

Inhalation Product DevelopmentManufacturingAnalytical ServicesFormulation DevelopmentProcess OptimizationDrug Product ManufacturingClinical Supply Supply ServicesBiologics ManufacturingPharmaceutical DevelopmentBiologics DevelopmentDrug FormulationDrug DeliveryClinical SupplyDrug Delivery SolutionsOral Solid Dose ManufacturingClinical Supply ServicesAnalytical TestingConsumer HealthSoftgel TechnologiesDrug DevelopmentPackagingSupply Chain

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Catalent Pharma Solutions, Inc. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Catalent Pharma Solutions, Inc. holds 0 active (74 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • SOFTGELS [OET 10275449 50]Inactive2019-04-11
  • SOFTGELS [OET - 10258984]Inactive2018-10-22
  • SOFTGELS [OET-10275547-9]Inactive2018-09-28
  • SOFTGELS [OET - 10275485]Inactive2017-12-15
  • SOFTGELS [OET: 10275427-9]Inactive2017-11-14
  • SOFTGELS [OET-10275412]Inactive2017-05-26
  • SOFTGELS [OET-10259015-17]Inactive2017-04-13
  • SOFTGELS [OET-10258867]Inactive2016-10-20
  • SOFTGELS [OET-10259014]Inactive2016-06-24
  • SOFTGELS [OET- 10275405-7]Inactive2016-06-21
  • SOFTGELS [OET-10275378]Inactive2015-12-15
  • SOFTGELS [OET-10275191]Inactive2015-01-16
  • SOFTGELS [OET-10275198]Inactive2014-10-22
  • SOFTGELS [OET-10275268]Inactive2014-03-24
  • SOFTGELS [OET-00775174]Inactive2013-12-12
  • SOFTGELS [OET-10275266]Inactive2013-12-06
  • SOFTGELS [OET-10275282]Inactive2013-10-30
  • SOFTGELS [OET-10275226]Inactive2013-10-24
  • SOFTGELS [OET-10275265]Inactive2013-06-24
  • SOFTGELS [OET-10275261]Inactive2013-03-26
  • SOFTGELS [OET-10275260]Inactive2013-01-15
  • SOFTGEL CAPSULE [OET-10275263]Inactive2013-01-15
  • SOFT GELATIN CAPSULE - OET-10275258Inactive2012-12-31
  • PALONOSETRON HC1 0.50 MG SOFTGELS (1.5 OVAL)Inactive2012-09-18
  • WC3042-05, CAPSULEInactive2012-05-31
  • WC3042-08P CAPSULEInactive2012-05-31
  • MDV3100, 40MG, CAPSULES (SOFTGELS)Inactive2012-02-22
  • AMR101 1G CAPSULESInactive2011-09-12
  • SOFTGELS [OET - 10258977]Inactive2010-12-17
  • SOFT GELATIN CAPSULE MANUFACTURING PROCESS FOR OET-10275167Inactive2010-12-10
  • DUTASTERIDE 0.5 MG SOFT GELATIN CAPSULESInactive2010-10-19
  • SOFTGELS [0775279]Inactive2010-09-01
  • DRONABINOL CAPSULES USP 2.5MG, 5.0MG, 10.0MG (CIII) SAInactive2010-05-27
  • PROGESTERONE SOFT GELATIN CAPSULES 100 MG AND 200 MGInactive2010-05-21
  • PROCARDIA SOFTGELS 10 MG (NIFEDIPINE)Inactive2009-09-18
  • ESTRADIOL VAGINAL SOFT GELATIN CAPSULESInactive2009-06-08
  • MICONAZOLE 1200 MG SOFTGELSInactive2007-06-22
  • MICONAZOLE GELATIN ENCAPSULATED VAGINAL SUPPOSITORY 200 MGInactive2006-11-08
  • SANDIMMUNE 25 MG AND 100 MG SOFTGELSInactive2005-11-30
  • R115866 SOFTGELSInactive2005-08-26
  • LORATADINE SOFTGELS (10 MG)Inactive2005-08-23
  • NIMODIPINE 30MG SOFTGELSInactive2005-05-24
  • NEORAL 25 MG AND 100 MG SOFTGELSInactive2005-04-13
  • PALONOSETRON HYDROCHLORIDE 0.50 MG SOFTGELSInactive2005-03-17
  • LUBIPROSTONE, 24 MCG CAPSULESInactive2005-02-11
  • TIPRANAVIR CAPSULES 250 MG (IMPRINTED)Inactive2004-10-26
  • ATRASENTAN HYDROCHLORIDE, SOFT GELATIN CAPSULES, 10 MG (BASE EQUIVALENT)Inactive2004-09-05
  • ZEMPLAR (PARACALCITOL) CAPSULES, 1 MCGInactive2004-05-20
  • RISPERIDONE 2.0 MG ORALLY DISINTEGRATING TABLETSInactive2004-03-24
  • CALCITRIOL 0.25 MCG SOFT GELATIN CAPSULESInactive2003-11-20

Showing the 50 most relevant of 74 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

Catalent Pharma Solutions, Inc. holds 3 active (6 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • PLANT BASED SHELLActive2022-10-13
  • GELATIN MASS FOR SOFTGEL CAPSULESActive2020-06-02
  • GELATIN MASS FOR SOFTGELSActive2020-03-27
  • SOFTGELS [OET 10275375-7]Inactive2016-05-19
  • SOFTGELS [OET-10275299]Inactive2014-11-03
  • GELATIN MASSESInactive2010-08-02

Registered manufacturing sites (14)

Physical sites registered with the US FDA and resolved to Catalent Pharma Solutions, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

18 FDA enforcement records linked to this company.

  • 4832026-05-22

    Written procedures not established/followed

  • 4832025-04-22

    Investigations of discrepancies, failures

  • 4832025-04-22

    Written procedures not established/followed

  • 4832024-05-24

    Cleaning / Sanitizing / Maintenance

  • 4832023-01-11

    Second person sign off

  • 4832022-12-15

    Sterility/pyrogens - test methods written, followed

  • 4832022-12-15

    Following/documenting laboratory controls

  • 4832022-12-15

    Establishment of calibration procedures

  • 4832022-12-15

    Test methods

  • 4832019-02-22

    Scientifically sound laboratory controls

  • 4832019-02-22

    Written program not followed

  • 4832019-02-22

    SOPs not followed / documented

  • 4832018-06-14

    Procedures for non-sterile drug products

  • 4832018-06-14

    Written in-process control procedures

  • 4832018-06-14

    Procedures not in writing, fully followed

  • 4832018-06-14

    Quality control unit review of records

  • 4832017-05-19

    Released Drug Products Area

  • 4832017-05-19

    Procedures not in writing, fully followed

For suppliers

Is this Catalent Pharma Solutions, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.